You just read:

Kyowa Kirin Presents Post-Hoc Analysis of Pivotal Trial for Poteligeo® (mogamulizumab-kpkc)

News provided by

Kyowa Hakko Kirin Co., Ltd.

Jun 03, 2019, 09:00 ET